Page 206 - பல்கலைக்கழகம் ஆஃப் வடக்கு கரோலினா இல் தேவாலயம் மலை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

An oral pill for COVID-19? Molnupiravir shows promise After more than one year into the coronavirus disease (COVID-19) pandemic, international vaccination efforts are moving closer to bringing this pandemic to an end. Though several drugs have been repurposed to help patients with COVID-19, scientists are still looking to discover antivirals that are effective against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19. Recently, researchers at the University of North Carolina at Chapel Hill reported molnupiravir as the first oral and direct-acting antiviral that is highly effective at reducing nasopharyngeal SARS-CoV-2 infectious virus and viral ribonucleic acid (RNA) levels.

United statesRidgeback biotherapeuticsMichal bednarek shutterstockUniversity of north carolina at chapel hillNorth carolinaChapel hillOral antiviral treatmentஒன்றுபட்டது மாநிலங்களில்பல்கலைக்கழகம் ஆஃப் வடக்கு கரோலினா இல் தேவாலயம் மலைவடக்கு கரோலினாதேவாலயம் மலை